Event, diagnostic imaging  

DOBI Medical International to exhibit ComfortScan system at the 2005 European Congress of Radiology

28 February 2005

MAHWAH, N.J., USA. DOBI Medical International, Inc. (DBMI.OB) announced today that the Company will exhibit their Dynamic Optical Breast Imaging (DOBI(R)) technology, known as the ComfortScan(TM) system, at the 2005 European Congress of Radiology (ECR), March 4-7, at the Austria Center Vienna (Booth 11, Extension Expo A).

More than 14,000 radiologists, non-radiologist physicians, radiographers, physicists, members of other scientific disciplines and individual members of commercial companies with a special radiology interest are expected to attend this seventeenth annual conference, one of the most prestigious radiology events in Europe.

According to the European Network of Cancer Registries, breast cancer is the most common cancer in females in Europe and it is estimated that breast cancer is responsible for 27% of all new cancer cases in European women.

The ComfortScan system is a non-invasive, non-ionizing device that uses light-emitting diodes (LEDs) and gentle external pressure to identify angiogenesis, the growth of new blood vessels, in the breast. Angiogenesis has often been associated with aggressive or malignant tumors. Since standard technologies, such as mammography and ultrasound, do not show blood vessel growth, the ComfortScan system can potentially improve the physician's ability to diagnose breast cancer.

DOBI Medical currently has nine international distributors representing 13 countries or approximately one-fifth of the world's population. The European distribution network includes Russia, the Czech Republic, Switzerland, Italy, Greece and the Netherlands.

For more information on DOBI Medical or the ComfortScan system, visit www.dobimedical.com.

Source: DOBI Medical


To top